N6-(2-Hydroxyethyl)adenosine

CAS No. 4338-48-1

N6-(2-Hydroxyethyl)adenosine( —— )

Catalog No. M37892 CAS No. 4338-48-1

N6-(2-Hydroxyethyl)adenosine, a Ca2+ antagonist and anti-inflammatory agent, is associated with the regulation of cerebral and coronary circulation and is believed to exhibit sedative activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
50MG 29 In Stock
100MG 43 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    N6-(2-Hydroxyethyl)adenosine
  • Note
    Research use only, not for human use.
  • Brief Description
    N6-(2-Hydroxyethyl)adenosine, a Ca2+ antagonist and anti-inflammatory agent, is associated with the regulation of cerebral and coronary circulation and is believed to exhibit sedative activity.
  • Description
    N6-(2-Hydroxyethyl)adenosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    GPCR/G Protein
  • Target
    Calcium Channel
  • Recptor
    Calcium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    4338-48-1
  • Formula Weight
    311.29
  • Molecular Formula
    C12H17N5O5
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    OCCNc1ncnc2n(cnc12)[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Man S, et al. Potential and promising anticancer drugs from adenosine and its analogs. Drug Discov Today. 2021 Jun;26(6):1490-1500.?
molnova catalog
related products
  • Nicardipine hydrochl...

    Nicardipine(YC-93) is a calcium channel blocker that has been widely used to control blood pressure in severe hypertension.

  • AMG1

    A novel specific CRAC channel inhibitor that blocks function of effector.

  • Atagabalin HCl

    Atagabalin HCl is a novel voltage-dependent calcium channel (VDCC) α2δ subunit (1 and 2) ligand that affects slow-wave sleep and can be used to treat insomnia.